Author: Vitaliy Dadalyan

California Tops N.Y. in Cases; U.S. Vaccine Deal: Virus Update

(Bloomberg) -- California has surpassed New York as the U.S. state with most confirmed Covid-19 infections. The U.S. sealed a pact for an initial 100 million doses of a vaccine Pfizer Inc. is developing with Germany’s BioNTech SE. The coronavirus tightened its grip on the Asia Pacific region, with deaths reaching a daily high in Indonesia and infections hitting records in Hong Kong and Japan. Cases also set a record in Australia, once hailed as a virus success story.Aviation regulators in the European Union and Singapore are working together to establish health measures and facilitate a recovery of air travel.Key Developments:Global Tracker: Cases near 15 million; deaths pass 617,000Month into the outbreak, U.S. testing still isn’t rightNew York taxes will stalk those who fled pandemicPreschooler parents are facing tough choices as offices reopenU.K. oil industry at odds with government on mass testingThe keys to speed in race for vaccine, and its...

U.S. Makes Vaccine Deal; Infections Grip Asia: Virus Update

(Bloomberg) -- The U.S. sealed a pact for an initial 100 million doses of a Covid-19 vaccine Pfizer Inc. is developing with Germany’s BioNTech SE. President Donald Trump warned that the U.S. outbreak will probably get worse before it gets better.The coronavirus tightened its grip on the Asia Pacific region, with deaths reaching a daily high in Indonesia and infections hitting records in Hong Kong and Japan. Cases also set a record in Australia, once hailed as a virus success story.Aviation regulators in the European Union and Singapore are working together to establish health measures and facilitate a recovery of air travel.Key Developments:Global Tracker: Cases near 15 million; deaths pass 617,000Month into the outbreak, U.S. testing still isn’t rightNew York taxes will stalk those who fled pandemicPreschooler parents are facing tough choices as offices reopenU.K. oil industry at odds with government on mass testingThe keys to speed in race for vaccine,...

These Loser Stocks Deserve a Lot More Love

(Bloomberg Opinion) -- Add the lackluster performance of defense stocks to the long list of puzzling inequities in the pandemic stock market. A custom basket of top U.S. defense contractors within the S&P 500 Index is down about 20% for the year, even as the broader benchmark pushed into the green this week. Even excluding Boeing Co., whose commercial aerospace travails are more of a focus for investors, the group is still down about 16%. That’s significantly worse than the performance for S&P 500 railroads, restaurants, foot-wear makers and soft-drink companies, all of which are more immediately exposed to the volatility of economic reopenings and behavioral shifts than makers of missiles, fighter jets and radar systems that rely on government contracts sealed years earlier. Lockheed Martin Corp., which reported second-quarter earnings on Tuesday, displayed the sector's resilience amid the pandemic upheaval. Earnings, sales and cash flow were all higher than the year-earlier period, with cash balances helped...